TGTX: with 130 mn in cash on its way up..

TG Therapeutics: A Strong Buy on Robust Briumvi Sales and Promising Pipeline Prospects

GS raises their price target. We only had to hit them in the head with a giant bat before they slightly changed their tune. We’re going to have to amputate on BOA to make their price target $12. It’s going to take a lot of work to fix BOA. That monster needs dealt with.